Observe Medical delivers 20 new ultrasound probes to Fresenius Medical Care
Oslo, October 17, 2023 - Observe Medical (OSE: OBSRV) Observe Medical ("the Company" or "Observe Medical") today announces that it has delivered 20 Biim ultrasound probes to Fresenius Medical Care in the US.
As part of the partnership agreement with Fresenius Medical Care, Observe Medical has delivered 20 Biim ultrasound probes to Fresenius Medical Care, and has at total now delivered 285 ultrasound probes to the leading provider of kidney care services in the US.
For the last 1.5 years the main focus for the Company has been educational and training support for approximately 265 educational dialysis clinics of Fresenius. According to Fresenius this support has been necessary and needed to optimize the use of the Biim technology amongst key personnel in Fresenius on a daily basis. The intention is to secure that Fresenius is ready for a broader implementation for use of the Biim ultrasound probe in all their approximately 2,700 dialysis clinics in the US.
“As earlier communicated, our relationship with Fresenius remains strong. Even if no guarantees can be given for the timeline and scope of a broader implementation, the order and delivery of 20 ultrasound probes confirms the strong commitment Fresenius have to implement the ultrasound technology in their dialysis clinics,” said Rune Nystad.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: [email protected]
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: [email protected]
About Fresenius Medical Care
Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. They care for approximately 345,000 patients in their global network of more than 4,000 dialysis clinics. At the same time, they operate 42 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
Fresenius Medical Care aim to continuously improve the patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.
Fresenius Medical Care’s corporate headquarters is in Bad Homburg v. d. Höhe, Germany. The headquarters in North America is in Waltham, Massachusetts, the headquarters of Asia-Pacific is located in Hong Kong and the headquarters of Latin America is in Rio de Janeiro, Brazil.
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.
Further information is available at www.observemedical.com.